Skip to main content
. 2023 Jan 20;24(3):2100. doi: 10.3390/ijms24032100
APP amyloid-β precursor protein
APLP2 amyloid-β precursor-like protein 2
BBB blood–brain barrier
CAF cancer-associated fibroblasts
CM conditioned media
CTSD cathepsin D
CTSZ cathepsin Z
ECM extracellular matrix
EFEMP1/FBLN3 fibulin 3
EMT epithelial–mesenchymal transition
ER estrogen receptor
EV extracellular vesicle
FBLN1 fibulin 1
FN fibronectin
FST follistatin
GDF15 growth differentiation factor 15
IGFBP insulin-like growth factor-binding protein
IRE1 inositol-requiring enzyme 1 alpha
LCN2 lipocalin 2
LDL low-density lipoprotein
LEC lymphatic endothelial cells
LPA lipoprotein A
MEC microvascular endothelial cells
MIC-1 macrophage inhibitory cytokine-1
MMP matrix metalloproteinase
MSC mesenchymal stromal cell
MTA microtubule-targeting agents
OGF opioid growth factor
PAI1 plasminogen activator inhibitor 1
PENK proenkephalin
PLAT tissue plasminogen activator
PLG plasminogen
PR progesterone receptor
SASP senescence-associated secretory phenotype
SERPINE1 serine peptidase inhibitor E1
SNPs single-nucleotide polymorphisms
STX sialyl transferase X
suPAR/PLAUR soluble form of the urokinase receptor
TF tissue factor
THBS1 thrombospondin
TIMP tissue inhibitor of metalloproteinases
TIS therapeutic-induced senescent
TME tumor microenvironment
TNBC triple-negative breast cancer
TSPAN11 tetraspanin 11
uPA/PLAU urokinase plasminogen activator
uPAR urokinase plasminogen activator receptor
VEGF vascular endothelial growth factor